Mostrar el registro sencillo del ítem

Effects of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19: A narrative review of the literature

dc.contributor.authorMuñoz Loaiza, Juan Davidspa
dc.contributor.authorInfante, Heitmar Santiagospa
dc.contributor.authorPérez Mahecha, Brenda Stefaníaspa
dc.contributor.authorHerrera Cardona, Juan Estebanspa
dc.contributor.authorSalamanca, David Ricardospa
dc.date.accessioned2020-08-11 00:00:00
dc.date.accessioned2022-03-08T16:19:03Z
dc.date.available2020-08-11 00:00:00
dc.date.available2022-03-08T16:19:03Z
dc.date.issued2020-08-11
dc.identifier.issn2389-7325
dc.identifier.urihttps://repositorio.uniboyaca.edu.co/handle/uniboyaca/393
dc.format.mimetypeapplication/pdfeng
dc.language.isoengeng
dc.publisherUniversidad de Boyacáspa
dc.rightsRevista Investigación en Salud Universidad de Boyacá - 2020eng
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0eng
dc.sourcehttps://revistasdigitales.uniboyaca.edu.co/index.php/rs/article/view/473eng
dc.subjectCoronavirusspa
dc.subjectInfecciones por Coronavirusspa
dc.subjectVirus del SARSspa
dc.subjectHipertensiónspa
dc.subjectInhibidores de la Enzima Convertidora de Angiotensinaspa
dc.subjectCoronaviruseng
dc.subjectCOVID-19eng
dc.subjectHypertensioneng
dc.subjectAngiotensin-Converting Enzyme Inhibitorseng
dc.subjectAngiotensin Receptor Antagonistseng
dc.subjectcoronavíruseng
dc.subjectCOVID-19eng
dc.subjecthipertensãoeng
dc.subjectinibidores da enzima de conversão da angiotensinaeng
dc.subjectantagonistas do receptor da angiotensinaeng
dc.titleEffects of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19: A narrative review of the literaturespa
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.identifier.doi10.24267/23897325.473
dc.identifier.eissn2539-2018
dc.identifier.urlhttps://doi.org/10.24267/23897325.473
dc.relation.bitstreamhttps://revistasdigitales.uniboyaca.edu.co/index.php/rs/article/download/473/544
dc.relation.citationeditionNúm. 2 , Año 2020 : Revista Investigación en Salud Universidad de Boyacáspa
dc.relation.citationendpage99
dc.relation.citationissue2spa
dc.relation.citationstartpage80
dc.relation.citationvolume7spa
dc.relation.ispartofjournalRevista Investigación en Salud Universidad de Boyacáspa
dc.relation.referencesMillán-Oñate J, Rodriguez-Morales AJ, Camacho-Moreno G, Mendoza-Ramírez H, Arturo Rodríguez-Sabogal I, Álvarez-Moreno C. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19). Infectio. 2020;24(3):187-92. http://dx.doi.org/10.22354/in.v24i3.848eng
dc.relation.referencesStedman KM. Deep Recombination: RNA and ssDNA Virus Genes in DNA Virus and Host Genomes. Annu Rev Virol. 2015;2(1):203–17. https://doi.org/10.1146/annurev-virology-100114-055127eng
dc.relation.referencesSyed A. Coronavirus: A Mini-Review. Int J Curr Res Med Sci. 2020;6(1):8–10. http://dx.doi.org/10.22192/ijcrms.2020.06.01.002eng
dc.relation.referencesKillerby ME, Biggs HM, Midgley CM, Gerber SI, Watson JT. Middle East Respiratory Syndrome Coronavirus Transmission. Emerg Infect Dis. 2020;26(2):191–8. https://dx.doi.org/10.3201/eid2602.190697eng
dc.relation.referencesGralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, Whitmore A, Heise MT, Baric RS. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. Subbarao K, editor. MBio. 2018;9(5):e01753-18. https://doi.org/10.1128/mBio.01753-18eng
dc.relation.referencesKhan S, Siddique R, Shereen MA, Ali A, Liu J, Bai Q, Bashir N, Xue M. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options. Kraft CS, editor. J Clin Microbiol. 2020;58(5): e00187-20. https://doi.org/10.1128/JCM.00187-20eng
dc.relation.referencesAshour HM, Elkhatib WF, Rahman MM, Elshabrawy HA. Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. Pathogens. 2020;9(3):186. https://doi.org/10.3390/pathogens9030186eng
dc.relation.referencesMadhugiri R, Fricke M, Marz M, Ziebuhr J. Coronavirus cis-Acting RNA Elements. Adv Virus Res. 2016;96:217-63. https://doi.org/10.1016/bs.aivir.2016.08.007eng
dc.relation.referencesOrtega JT, Serrano ML, Pujol FH, Rangel HR. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis. EXCLI J. 2020;19:410–7. https://doi.org/10.17179/excli2020-1167eng
dc.relation.referencesHoffmann M, Kleine-Weber H, Pöhlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Molecular Cell. 2020;78(4):779-784.e5. https://doi.org/10.1016/j.molcel.2020.04.022eng
dc.relation.referencesHoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271–80. https://doi.org/10.1016/j.cell.2020.02.052eng
dc.relation.referencesZhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3. https://doi.org/10.1038/s41586-020-2012-7eng
dc.relation.referencesTouyz RM, Li H, Delles C. ACE2 the Janus-faced protein – from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19. Clin Sci. 2020;134(7):747–50. https://doi.org/10.1042/cs20200363eng
dc.relation.referencesKuba K, Imai Y, Penninger JM. Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases. Circulation Journal. 2013;77(2):301-8. https://doi.org/10.1253/circj.cj-12-1544eng
dc.relation.referencesQi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020;526(1):135–40. https://doi.org/10.1016/j.bbrc.2020.03.044eng
dc.relation.referencesAtri D, Siddiqi HK, Lang J, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies. JACC Basic to Transl Sci. 2020;443. https://doi.org/10.1016/j.jacbts.2020.04.002eng
dc.relation.referencesChen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097–100. https://doi.org/10.1093/cvr/cvaa157eng
dc.relation.referencesBertram S, Heurich A, Lavender H, Gierer S, Danisch S, Perin P, Lucas JM, Nelson PS, Pöhlmann S, Soilleux EJ. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One. 2012;7(4):e35876. https://doi.org/10.1371/journal.pone.0035876eng
dc.relation.referencesLiu PP, Blet A, Smyth D, Li H. The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation. 2020;142(1):68-78. https://doi.org/10.1161/CIRCULATIONAHA.120.047549eng
dc.relation.referencesKreutz R, Algharably EA, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer TG, Wang JG, Burnier M. Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Cardiovasc Res. 2020;116(10):1688-1699. https://doi.org/10.1093/cvr/cvaa097eng
dc.relation.referencesAkobeng AK. Principles of evidence based medicine. Archives of disease in childhood 2005;90(8):837-40. http://dx.doi.org/10.1136/adc.2005.071761eng
dc.relation.referencesRomero CA, Orias M, Weir MR. Novel RAAS agonists and antagonists: Clinical applications and controversies. Nature Reviews Endocrinology. 2015;11(4):242-52. https://doi.org/10.1038/nrendo.2015.6eng
dc.relation.referencesPatel VB, Zhong JC, Grant MB, Oudit GY. Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure. Circulation Research. 2016;118(8):1313-26. https://doi.org/10.1161/CIRCRESAHA.116.307708eng
dc.relation.referencesChappell MC, Marshall AC, Alzayadneh EM, Shaltout HA, Diz DI. Update on the angiotensin converting enzyme 2-angiotensin (1-7)-Mas receptor axis: Fetal programing, sex differences, and intracellular pathways. Frontiers in Endocrinology. 2014;4:201. https://doi.org/10.3389/fendo.2013.00201eng
dc.relation.referencesJiang F, Yang J, Zhang Y, Dong M, Wang S, Zhang Q, Liu FF, Zhang K, Zhang C. Angiotensin-converting enzyme 2 and angiotensin 1-7: Novel therapeutic targets. Nature Reviews Cardiology. 2014;11(7):413-26. https://doi.org/10.1038/nrcardio.2014.59eng
dc.relation.referencesCheng H, Wang Y, Wang G-Q. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J Med Virol. 2020;92(7):726-730. https://doi.org/10.1002/jmv.25785eng
dc.relation.referencesTikellis C, Bernardi S, Burns WC. Angiotensin-converting enzyme 2 is a key modulator of the renin–angiotensin system in cardiovascular and renal disease. Curr Opin Nephrol Hypertens. 2011;20(1):62–8. https://doi.org/10.1155/2012/256294eng
dc.relation.referencesLi S-R, Tang Z-J, Li Z-H, Liu X. Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV. Eur J Clin Microbiol Infect Dis. 2020;39(6):1021–6. https://doi.org/10.1007/s10096-020-03883-yeng
dc.relation.referencesSouth AM, Diz D, Chappell MC. COVID-19, ACE2 and the Cardiovascular Consequences. Am J Physiol Hear Circ Physiol. 2020;318(5):H1084–90. https://doi.org/10.1152/ajpheart.00217.2020eng
dc.relation.referencesHanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM. Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System-a Call for Epidemiologic Investigations. Clin Infect Dis. 2020; ciaa329. https://doi.org/10.1093/cid/ciaa329eng
dc.relation.referencesAkhmerov A, Marban E. COVID-19 and the Heart. Circ Res. 2020;126(10):1443–55. https://doi.org/10.1161/CIRCRESAHA.120.317055eng
dc.relation.referencesHuang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5eng
dc.relation.referencesLeng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S, Fan J. Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020;11(2):216–28. https://doi.org/10.14336/ad.2020.0228eng
dc.relation.referencesGuan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur Respir J. 2020;55(5):2000547. https://doi.org/10.1183/13993003.00547-2020eng
dc.relation.referencesChen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. https://doi.org/10.1136/bmj.m1091eng
dc.relation.referencesWang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - J Am Med Assoc. 2020;323(11):1061–9. https://doi.org/10.1001/jama.2020.1585eng
dc.relation.referencesYang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5. https://doi.org/10.1016/j.ijid.2020.03.017eng
dc.relation.referencesLippi G, Wong J, Henry BM. Hypertension in Patients With Coronavirus Disease 2019 (COVID-19): A Pooled Analysis. Polish Arch Intern Med. 2020;130(4):304–9. https://doi.org/10.20452/pamw.15272eng
dc.relation.referencesWang L, He W, Yu X, Hu D, Bao M, Liu H, Zhou J, Jiang H.. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80(6):639–45. https://doi.org/10.1016/j.jinf.2020.03.019eng
dc.relation.referencesTurner AJ, Tipnis SR, Guy JL, Rice GI, Hooper NM. ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors. Can J Physiol Pharmacol. 2002;80(4):346–53. https://doi.org/10.1139/y02-021eng
dc.relation.referencesFerrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Smith RD, Chappell MC. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney International. 2005;68(5):2189-96. https://doi.org/10.1111/j.1523-1755.2005.00675.xeng
dc.relation.referencesLi G, He X, Zhang L, Ran Q, Wang J, Xiong A, Wu D, Chen F, Sun J, Chang C. Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19. J Autoimmun. 2020;102463. https://doi.org/10.1016/j.jaut.2020.102463eng
dc.relation.referencesRico-Mesa JS, White A, Anderson AS. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB. Curr Cardiol Rep. 2020;22(5):31. https://doi.org/10.1007/s11886-020-01291-4eng
dc.relation.referencesHulot J-S. COVID-19 in patients with cardiovascular diseases. Arch Cardiovasc Dis. 2020;113(4):225–6. https://doi.org/10.1016/j.acvd.2020.03.009eng
dc.relation.referencesLuca Roncati, Graziana Gallo, Antonio Manenti BP. Roncati L, Gallo G, Manenti A, Palmieri B. Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2. 2020;140:109686. https://doi.org/10.1016/j.mehy.2020.109686eng
dc.relation.referencesEsler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? J Hypertens. 2020;38(5):781–2. https://doi.org/10.1097/hjh.0000000000002450eng
dc.relation.referencesSingh AK, Gupta R, Misra A. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):283–7. https://doi.org/10.1016/j.dsx.2020.03.016eng
dc.relation.referencesMuniyappa R GS Muniyappa R, Gubbi S. Perspective: COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus. Am J Physiol Metab. 2020;318(5):E736-41. https://doi.org/10.1152/ajpendo.00124.2020eng
dc.relation.referencesBattistoni A, Volpe M. Might renin-angiotensin system blockers play a role in the COVID-19 pandemic? Eur Hear journal Cardiovasc Pharmacother. 2020. https://doi.org/10.1093/ehjcvp/pvaa030eng
dc.relation.referencesRossi GP, Sanga V, Barton M. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients. Elife. 2020;9:e57278. https://doi.org/10.7554/elife.57278eng
dc.relation.referencesDanser AHJ, Epstein M, Batlle D. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers. Hypertension. 2020;75(6):1382–1385. https://doi.org/10.1161/HYPERTENSIONAHA.120.15082eng
dc.relation.referencesMalha L, Mueller FB, Pecker MS, Mann SJ, August P, Feig PU. COVID-19 and the Renin-Angiotensin System. Kidney Int Reports. 2020;5(5):563–5. https://doi.org/10.1016/j.ekir.2020.03.024eng
dc.relation.referencesMeng J, Xiao G, Zhang J, He X, Ou M, Bi J, Yang R, Di W, Wang Z, Li Z, Gao H. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect. 2020;9(1):757–60. https://doi.org/10.1080/22221751.2020.1746200eng
dc.relation.referencesGuan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. https://doi.org/10.1056/NEJMoa2002032eng
dc.relation.referencesZhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, Liu YM, Zhao YC, Huang X, Lin L, Xia M. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19. Circ Res. 2020. https://doi.org/10.1161/CIRCRESAHA.120.317134eng
dc.relation.referencesTalreja H, Tan J, Dawes M, Supershad S, Rabindranath K, Fisher J, Valappil S, Wong L, van der Merwe W, Paton J.. A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019). N Z Med J. 2020;133(1512):85–7eng
dc.relation.referencesMehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, Carmona-Rubio AE, Jacob M, Procop GW, Harrington S, Milinovich A. Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 2020 May 5;e201855. https://doi.org/10.1001/jamacardio.2020.1855eng
dc.relation.referencesSommerstein R, Kochen MM, Messerli FH, Gräni C. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? J Am Heart Assoc. 2020;9(7):e016509. https://doi.org/10.1161/JAHA.120.016509eng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccesseng
dc.rights.creativecommonsEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.eng
dc.title.translatedEfectos de Bloqueadores del Receptor de Angiotensina II e inhibidores de la Enzima Convertidora de Angiotensina en COVID-19: Una revisión narrativa de la literaturaeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501eng
dc.type.coarhttp://purl.org/coar/resource_type/c_dcae04bceng
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85eng
dc.type.contentTexteng
dc.type.driverinfo:eu-repo/semantics/articleeng
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREVeng
dc.type.versioninfo:eu-repo/semantics/publishedVersioneng
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2eng


Ficheros en el ítem

FicherosTamañoFormatoVer
Revista Investig. Salud Univ. Boyacá-473.pdf456.7Kbapplication/pdfVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Revista Investigación en Salud Universidad de Boyacá - 2020
Excepto si se señala otra cosa, la licencia del ítem se describe como Revista Investigación en Salud Universidad de Boyacá - 2020